Brief: U.S. FDA's office of orphan products development issues grant supporting gensperas glioblastoma study
17/06/2015 13:30
June 17 (Reuters) - Genspera Inc GNSZ.PK : * U.S. food and drug administration's office of orphan products development issues grant supporting gensperas glioblastoma study * Source text for Eikon ID:nMKW8BH3Ka * Further company coverage GNSZ.PK ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rebus Holdings
See all newsBrief: Inspyr Therapeutics secures $100 mln financing agreement from Milost Global
Brief: Inspyr Therapeutics appoints senior vice president
Brief: Genspera announces private placement of $2.5 million
Brief: U.S. FDA's office of orphan products development issues grant supporting gensperas glioblastoma study